Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Frontiers in Oncology|December 17, 2020
Anti-Angiogenic Agents in Management of Sarcoma Patients: Overview of Published TrialsPierre-Yves Cren, Loïc Lebellec, Thomas Ryckewaert, et al.Bulletin Du Cancer|July 8, 2025
[Brain metastases in breast cancer: Diagnosis and management]Stéphanie Bécourt, Claire Cheymol, Pierre-Yves Cren, et al.Acta Oncologica (Stockholm, Sweden)|May 14, 2020
Maintenance therapy and drug holiday in sarcoma patients: systematic reviewLoïc Lebellec, Anne-Sophie Defachelles, Pierre-Yves Cren, et al.Melanoma Research|March 7, 2020
Symptomatic acute hypotension associated with high-dose dacarbazinePierre-Yves Cren, Guillaume Marliot, Diane Pannier, et al.Journal of Medical Case Reports|December 6, 2022
Myositis ossificans circumscripta after surgery and radiotherapy and during sunitinib treatment: a case reportPierre-Yves Cren, Nicolas Penel, Abel Cordoba, et al.Bulletin Du Cancer|March 29, 2024
Why do second-cycle medical students choose oncology? A literature overviewEstelle M N Laurent, Christophe Ducrocq, Pierre-Yves Cren, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 7, 2026
Optimizing Care for Patients With Metastatic Castration-Resistant Prostate CancerPierre-Yves Cren, James Buteau, Umma Fatema, et al.BMC Medical Education|March 28, 2025
Motivational factors influencing the choice of oncology as a specialty among French medical studentsNicolas Penel, Pierre-Yves Cren, Christophe Ducroq, et al.Cancer Medicine|March 25, 2024
Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective studyCôme De Metz, Benjamin Hennart, Estelle Aymes, et al.Bulletin Du Cancer|February 8, 2022
[Feedback on the first three years of application of the reform of the third cycle in oncology]Pierre-Yves Cren, Julie Chartier, Nicolas Penel, et al.Pageof 2